• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Glob Health Med . Elevated high-sensitivity troponin is associated with subclinical cardiac dysfunction in patients recovered from coronavirus disea

tetano

Editor, Senior Moderator
Glob Health Med


. 2021 Apr 30;3(2):95-101.
doi: 10.35772/ghm.2021.01025.
Elevated high-sensitivity troponin is associated with subclinical cardiac dysfunction in patients recovered from coronavirus disease 2019


Hiromasa Hayama[SUP] 1 2 [/SUP], Satoshi Ide[SUP] 3 [/SUP], Masao Moroi[SUP] 1 2 [/SUP], Yui Kitami[SUP] 1 [/SUP], Norifumi Bekki[SUP] 1 [/SUP], Shuji Kubota[SUP] 1 [/SUP], Yukari Uemura[SUP] 4 [/SUP], Hisao Hara[SUP] 1 [/SUP], Satoshi Kutsuna[SUP] 3 [/SUP], Norio Ohmagari[SUP] 3 [/SUP], Yukio Hiroi[SUP] 1 [/SUP]



Affiliations

Abstract

The aim of this study is to investigate myocardial damage in recovering coronavirus disease 2019 (COVID-19) patients with high-sensitivity troponin levels (hsTnT) and echocardiography. In this single-center cohort study, 215 COVID-19 recovered patients were recruited from all over Japan between April and September 2020. Demographic characteristics, hsTnT levels, and echocardiography data were collected for 209 patients, after excluding those without serum samples or good-quality echocardiographic images. The mean (? standard deviation) age was 44 (? 12) years (range: 36-55 years), and 50.7% of the patients were males. The median time interval (interquartile range) from COVID-19 onset to post-recovery examination was 56 days (34-96 days). Seventy-four recovered patients (35.4%) had hsTnT less than detection sensitivity (< 3 pg/mL) and 135 recovered patients (64.6%) had hsTnT ? 3 pg/mL. Ejection fraction was more than 50% in all cases. Left ventricular global longitudinal strain (LVGLS) and right ventricular free-wall longitudinal strain (RVFWLS) were reduced in 62 (29.7%) and 8 patients (3.8%), respectively. They were significantly associated with elevated hsTnT levels. In cases with hsTnT above 5 pg/mL, the LVGLS was greatly reduced to 19.0 ? 2.2% (p < 0.001). Multivariate linear regression analysis showed that elevated hsTnT level was an independent predictor of reduced LVGLS (standardized ? = -0.34; p < 0.001). In recovered COVID-19 patients, even a slight increase in hsTnT above detection sensitivity was associated with decreased LVGLS. hsTnT and echocardiography may be useful tools to detect myocardial injury in recovered COVID-19 patients.

Keywords: COVID-19; COVID-19 sequelae; high-sensitivity troponin levels; left ventricular global longitudinal strain; myocardial injury.
 
Back
Top Bottom